If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
212.00    4.00 (1.92%)
Bid:
211.50
Ask:
212.00
Spread: 0.50 (0.236%)
Market Cap: £586.00m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Trading Update

6 May 2021 07:00

RNS Number : 6932X
Morgan Advanced Materials PLC
06 May 2021
 

 

Press Release

Morgan Advanced Materials plc

06 May 2021

 

Trading update

 

Current trading

 

Sales for the first four months of the year to April 2021 were 2.5% higher for the Group, on an organic constant currency basis, compared to the same period last year.

 

By business, the organic constant currency trends for the four months to April 2021 compared to the same period last year were as follows:

 

- Thermal Products division sales were 3.7% higher, with growth in Molten Metal Systems and Thermal Ceramics.

- Carbon & Technical Ceramics division sales were 1.7% higher, with growth in Electrical Carbon and Technical Ceramics offsetting a decline in Seals & Bearings.

 

With respect to orders, we have seen an improving performance since the position reported at the year end, with average daily order intake ahead of the same period in 2020.

 

 

Outlook

 

With the good performance seen so far this year and positive order trends, we are raising our guidance for the Group's organic constant currency sales growth to be in the range of 5 to 8% for the full year, assuming no significant Covid related operating restrictions. Operating margins are expected to improve driven by volume leverage and the benefit of our restructuring programme announced last year.

 

 

Pete Raby, Chief Executive Officer, said:

 

"We are pleased with the momentum and return to organic sales growth, driving an upgrade in our guidance for the full year. This, together with the benefits from our restructuring actions, is expected to deliver improved profitability for the year."

 

 

For further enquiries:

 

Pete Raby

Morgan Advanced Materials plc

01753 837 000

Peter Turner

 

 

 

 

 

 

Nina Coad

 

 

Brunswick

 

0207 404 5959 

 

 

This announcement contains inside information. The person responsible for the release of this announcement on behalf of Morgan Advanced Materials plc is Peter Turner, Chief Financial Officer

 

LEI: I4K14LL95N2PHDL7EG85

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKPBDOBKDPPK
Date   Source Headline
5th Jun 20153:29 pmRNS2014 Environmental, Health and Safety Report
28th May 201511:22 amRNSHolding(s) in Company
20th May 20157:00 amRNSTrading Update
8th May 20153:51 pmRNSResult of AGM
16th Apr 20154:14 pmRNSDirector/PDMR Shareholding
2nd Apr 20158:40 amRNSDirector/PDMR Shareholding
31st Mar 20153:18 pmRNSHolding(s) in Company
31st Mar 20153:14 pmRNSDirector/PDMR Shareholding
31st Mar 201510:12 amRNSPublication of 2014 Annual Report
27th Mar 20159:41 amRNSDirector/PDMR Shareholding
26th Mar 20152:37 pmRNSDirector/PDMR Shareholding
25th Mar 20152:33 pmRNSDirector/PDMR Shareholding
24th Mar 20151:42 pmRNSDirector/PDMR Shareholding
24th Mar 20151:36 pmRNSDirector/PDMR Shareholding
2nd Mar 201512:32 pmRNSDirector/PDMR Shareholding
26th Feb 20152:05 pmRNSDirector/PDMR Shareholding
12th Feb 20157:00 amRNSFY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2014
30th Jan 20157:00 amRNSAppointment of Chief Executive Officer
23rd Dec 20142:03 pmRNSStatement under s.430 (2B) Companies Act 2006
23rd Dec 20142:00 pmRNSStatement under s. 430(2B) Companies Act 2006
18th Dec 201412:08 pmRNSHolding(s) in Company
18th Dec 201412:00 pmRNSDirector/PDMR Shareholding
16th Dec 201410:05 amRNSBlocklisting Interim Review
12th Dec 20141:05 pmRNSBoard Changes
3rd Dec 201410:47 amRNSDirector/PDMR Shareholding
1st Dec 20148:49 amRNSRejection of Vesuvius Proposal
1st Dec 20147:00 amRNSStatement of intention not to make an offer
11th Nov 20147:00 amRNSTrading Update
17th Oct 201410:17 amRNSMorgan Advanced Matereals - CDP Announcement
14th Oct 20149:29 amRNSHolding(s) in Company
2nd Oct 201411:25 amRNSDirector/PDMR Shareholding
29th Sep 20147:00 amRNSBoard Change
23rd Sep 20149:42 amRNSHolding(s) in Company
22nd Aug 201410:59 amRNSHolding(s) in Company
18th Aug 201410:16 amRNSHalf Yearly Report
5th Aug 20149:53 amRNSUNIVERSITY OF MANCHESTER PARTNERS WITH MORGAN
1st Aug 20149:18 amRNS£15m Composites & Defence Systems Contract Award
31st Jul 20142:13 pmRNSDirector/PDMR Shareholding
23rd Jul 20147:00 amRNSHalf Year Results
18th Jul 20149:25 amRNSDirector Declaration
15th Jul 20147:00 amRNSAcquisition of Porextherm Dämmstoffe GmbH
14th Jul 20149:15 amRNSDirector Declaration
18th Jun 20148:16 amRNSChange of Directors' responsibilities
16th Jun 201412:01 pmRNSBlocklisting Interim Review
9th Jun 20143:10 pmRNSHolding(s) in Company
9th Jun 201412:28 pmRNSAcquisition of Porextherm Dämmstoffe GmbH
9th Jun 201410:39 amRNSDirector/PDMR Shareholding
9th May 20143:39 pmRNSResult of AGM
9th May 20147:00 amRNSInterim Management Statement
9th Apr 201410:42 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.